AI-Powered blood test aims to spot colorectal cancer

NCT ID NCT06889844

Recruiting now Diagnosis Sponsor: ADVANCED MARKER DISCOVERY S.L. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test that uses artificial intelligence to find markers for colorectal cancer. Researchers want to see how often the test gives a false positive result in 250 people who have other cancers or gut diseases. Participants give one blood sample, and their medical records are checked for risk factors. The goal is to make colorectal cancer diagnosis easier and more accurate.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: blood test
What this could lead to: If successful, this could lead to a simple, accurate blood test to help diagnose colorectal cancer earlier.
What could go wrong: This is an early observational study, not a treatment trial. The test may still have false positives or not work as well in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Hospital Centro Médico Asturias
RECRUITING

Oviedo, Cantabria, Spain
Hospital Universitario HM Sanchinarro
RECRUITING

Madrid, Madrid, Spain
Hospital Universitario de Ourense
RECRUITING

Ourense, Galicia, Spain
Hospitales HM de Malaga
RECRUITING

Málaga, Andalusia, Spain
MD Anderson Cancer Centre
ACTIVE_NOT_RECRUITING

Madrid, Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.